Schering-Plough reports stable first quarter
22 April 2009
Katie McQue
Please Login to read the full article.
22 April 2009
Katie McQue
katie.mcque@informa.com
Schering-Plough's first-quarter profits almost trebled to $767 million after the previous year was affected by the costs associated with the Organon acquisition.
However, net sales were down by 6% to $4.4 billion owing to a negative 10% foreign exchange impact. As a result, sales of prescription...
Please Login to read the full article.
RELATED CONTENT
NEWS
- GBA to decide on future of Merck's ezetimibe after German assessment sees no benefit
- Teva in US agrees to 2017 for Vytorin generic, as Merck has other pending cases
- NICE green light helps Merck offer RA patients wider treatment choice
- Merck fails to secure expanded indications for two cardiovascular products
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
